BBHC (TRNX) 10-K 12 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 02, 2015	Jun. 30, 2014
Document Information [Line Items]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	MAGNEGAS CORP
Entity Central Index Key	1353487
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$38,518,147.94
Trading Symbol	MNGA
Entity Common Stock, Shares Outstanding		37,241,505

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash	$5,061,674	$216,523
Accounts receivable, net of allowance for doubtful accounts of $104,028 and $83,069, respectively	268,308	125,930
Inventory (including units for resale), at cost	2,164,838	1,710,066
Prepaid and other current assets	300,065	46,473
Total Current Assets	7,794,885	2,098,992
Property and equipment, net of accumulated depreciation of $961,520 and $661,744, respectively	6,353,655	5,306,152
Deferred tax asset	0	0
Intangible assets, net of accumulated amortization of $296,914 and $248,446, respectively	492,252	482,824
Investment in joint ventures	718,246	490,410
Security Deposits	21,647	8,568
Goodwill	2,098,069
Total Assets	17,478,754	8,386,946
Current Liabilities
Accounts payable	155,909	231,008
Accrued expenses	52,120	341,579
Deferred revenue and customer deposits	56,666	179,339
Total Current Liabilities	264,695	751,926
Liabilities, Noncurrent [Abstract]
Note Payable	520,000	0
Total Liabilities	784,695	751,926
Stockholders' Equity
Preferred stock: $0.001 par; 10,000,000 authorized; 1,002,000 issued and outstanding, respectively	1,002	1,000
Common stock: $0.001 par; 900,000,000 authorized; 36,691,505 and 23,259,109 issued and outstanding, respectively	36,692	23,259
Additional paid-in capital	42,361,549	26,163,522
Issued and unearned stock compensation	0	0
Accumulated deficit	-25,705,184	-18,552,761
Total Stockholders' Equity	16,694,059	7,635,020
Total Liabilities and Stockholders' Equity	$17,478,754	$8,386,946

Balance_Sheets_Parenthetical

Balance Sheets [Parenthetical] (USD $)	Dec. 31, 2014	Dec. 31, 2013
Allowance for doubtful accounts	$104,028	$83,069
Accumulated depreciation	961,520	661,744
Accumulated amortization	$296,914	$248,446
Preferred stock, par value	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	1,002,000	1,002,000
Preferred Stock, Shares Outstanding	1,002,000	1,002,000
Common Stock, Par or Stated Value Per Share	$0.00	$0.00
Common Stock, Shares Authorized	900,000,000	900,000,000
Common Stock, Shares, Issued	36,691,505	36,691,505
Common Stock, Shares, Outstanding	23,259,109	23,259,109

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue	$1,023,046	$988,986
Direct Costs	673,867	548,478
Gross Profit	349,179	440,508
Operating Expenses:
Selling, General, and Administration	3,500,448	3,488,600
Net loss on of settlement contracts and Revaluation of assets	0	622,103
Investor Relations & Public Expense	475,025	198,901
Stock-based employee & director compensation	1,511,988	1,465,888
Stocks issued to pay for services	1,245,320	318,361
Research and Development	387,058	179,559
Depreciation and Amortization	376,640	484,907
Total Operating Expenses	7,496,480	6,758,319
Operating Income (Loss)	-7,147,301	-6,317,811
Other Income and (Expense)	-5,151	-913
Total Other Income (Expense)	-5,151	-913
Net Income (Loss) before tax provision	-7,152,452	-6,318,724
Provision for Income Taxes		0
Net Income (Loss)	($7,152,452)	($6,318,724)
Basic (in dollar per share)	($0.23)	($0.29)
Diluted (in dollar per share)	($0.23)	($0.29)
Weighted average common shares:
Basic and diluted (in shares)	31,762,338	21,781,076

Statement_of_Changes_in_Stockh

Statement of Changes in Stockholders' Equity (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Unearned Stock [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2012	$10,058,513	$1,000	$20,044	$22,284,841	($13,333)	($12,234,039)
Balance (in shares) at Dec. 31, 2012		1,000,000	20,042,614
Compensation recognized under consulting agreement, May 31, 2008	13,333				13,333
Common shares issued:	2,511,576		2,822	2,508,754
Common shares issued: (Shares)			2,821,889
Offerings costs	-125,981			-125,981
Issued in exchange for services	1,496,303		394	1,495,908
Issued in exchange for services, (shares)			394,606
Net income (loss)	-6,318,724					-6,318,722
Balance at Dec. 31, 2013	7,635,020	1,000	23,259	26,163,522	0	-18,552,761
Balance (in shares) at Dec. 31, 2013		1,000,000	23,259,109
Private placement	14,000,000	6	7,501	13,992,493
Private placement, (shares)		6,242	3,500,755
Offerings costs	-1,483,818			-1,483,818
Issued in exchange for services	1,517,320		960	1,516,360
Issued in exchange for services, (shares)			959,499
Options - Stock Comp	1,511,989			1,511,989
Options exercised	666,000		600	665,400
Options exercised, (shares)			600,000
Preferred shares converted to Common Stock	0	-4	4,372	-4,368
Preferred shares converted to Common Stock, (shares)		-4,242	4,372,142
Net income (loss)	-7,152,452					-7,152,452
Balance at Dec. 31, 2014	$16,694,059	$1,002	$36,692	$42,361,578	$0	($25,705,184)
Balance (in shares) at Dec. 31, 2014		1,002,000	36,691,505

Statement_of_Cash_Flows

Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows from Operations
Net income (loss)	($7,152,452)	($6,318,724)
Adjustments to reconcile net loss to cash used in operating Activities:
Depreciation and amortization	376,640	484,907
Stock compensation	1,511,988	1,465,888
Stocks issued for Services	1,517,320
Provision for bad debt	-104
Loss on disposal of Fixed Assets	939
Revaluation of Inventory	-180,000
Revaluation of Assets		922,754
Gain on Settlement		-43,750
Changes in operating assets:
Accounts receivable	-8,750	-6,723
Inventory	62,228	-64,088
Prepaid and other current assets	-253,592	2,793
Security deposits	-13,034	-6,417
Accounts payable	-78,122	-252,681
Accrued expenses	-299,320	245,723
Deferred revenue and customer deposits	-122,673	-53,991
Total adjustments to net income	2,513,520	2,694,415
Net cash (used in) operating activities	-4,638,932	-3,624,309
Cash Flows from Investing Activities
Acquisition of property, plant & equipment	-465,584	-15,404
Acquisition of Subsidiary	-3,000,000
Investment in Joint Venture	-227,836
Acquisition of Intangibles	-57,896
Net cash flows (used in) investing activities	-3,751,316	-15,404
Cash Flows from Financing Activities
Proceeds from issuance of common stock	13,182,153	2,385,594
Net cash flows provided by (used in) investing activities	13,182,153	2,385,594
Net increase (decrease) in cash	4,791,905	-1,254,119
Cash balance, beginning	216,523	1,470,642
Cash balance, ending	5,061,674	216,523
Supplemental disclosure of cash flow information and non cash investing and financing activities:
Interest paid	8,554	1,269
Taxes paid	0	0
Non-cash transactions:
Capitalized construction cost for units placed in service	264,995	549,772
Stock issued as investment in Joint Venture	$200,000

Background_Information

Background Information	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background Information [Text Block]	1.                Background Information
	MagneGas Corporation (the “Company”) was organized in the state of Delaware on December 9, 2005. The Company was originally organized under the name 4307, Inc., for the purpose of locating and negotiating with a business entity for a combination. On April 2, 2007 all the issued and outstanding shares of 4307, Inc. were purchased and the Company name was changed to MagneGas Corporation.
	MagneGas Corporation is an alternative energy company that creates and produces hydrogen based alternative fuel through the gasification of carbon-rich liquids including certain liquids and liquid wastes. We have developed a process which transforms various types of liquid waste through a proprietary plasma arc machine. A byproduct of this process is to produce an alternative to natural gas currently sold in the metalworking market. We produce gas bottled in cylinders for the purpose of distribution to the metalworking market as an alternative to acetylene. We also are developing advanced uses of our fuel to co-combust with other fuels to reduce emissions. Additionally, we market, for sale or licensure, our proprietary plasma arc technology. Through the course of our business development, we have established retail and wholesale platforms to sell our fuel for use in the metalworking and manufacturing industries. In 2010, we recognized our initial sale of a Plasma Arc Flow unit and are continuing efforts to sell or lease additional equipment to end users.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2.                Summary of Significant Accounting Policies
	The significant accounting policies followed are:
	Basis of Presentation
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates.
	Use of Estimates
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The financial statements presented include estimates for patent life, recoverability of deferred tax assets and collections on our receivables. Our estimates include consideration of the useful lives of our intellectual property, allocations to research and development costs and recognition of deferred tax assets.
	Variable Interest Entities
	The Company considers the consolidation of entities to which the usual condition (ownership of a majority voting interest) of consolidation does not apply, focusing on controlling financial interests that may be achieved through arrangements that do not involve voting interest. If an enterprise holds a majority of the variable interests of an entity, it would be considered the primary beneficiary. The primary beneficiary is generally required to consolidate assets, liabilities and non-controlling interests at fair value (or at historical cost if the entity is a related party) and subsequently account for the variable interest as if it were consolidated based on a majority voting interest. The Company has investments in joint ventures that are in development of the MagneGas technology, however the Company is not identified as a primary beneficiary; therefore no consolidation is required and the investments are listed at their cost.
	Fair Value of Financial Instruments
	In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
	⋅	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
	⋅	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e. g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	⋅	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.
	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.
	The Company applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.
	Cash and Cash Equivalents
	The majority of cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. At December 31, 2014, nothing exceeded the Federal Deposit Insurance Corporation (FDIC) limits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
	Accounts Receivable, Credit
	Accounts receivable consist of amounts due for the delivery of MagneGas sales to customers. An allowance for doubtful accounts is considered to be established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, and current economic trends. Based on management’s review of accounts receivable, allowances for doubtful accounts were established as deemed necessary. Receivables are determined to be past due, based on payment terms of original invoices. Reserves for uncollectible accounts were $104,028 for 2014 as compared to $83,069 in 2013. The Company does not typically charge interest on past due receivables.
	Revenue Recognition
	The Company generates revenue through two processes: (1) Sale of MagneGas fuel for metal cutting and (2) Sale of its Plasma Arc Flow units. Additionally we also recognize revenue from territorial license arrangements.
	⋅	Revenue for metalworking fuel is recognized when shipments are made to customers. The Company recognizes a sale when the product has been shipped and risk of loss has passed to the customer.
	⋅	Revenue generated from sales of its production unit is recognized on a percentage of completion, based on the progress during manufacturing of the unit. Our machine is a significant investment and generally requires a 6 to 9 month production cycle. During the course of building a unit the actual costs are tracked to our cost estimates and revenue is proportionately recognized during the process. Significant deposits are required before production. These deposits are classified as customer deposits.
	⋅	Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories. We recognize revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement.
	Inventories
	Inventories are stated at the lower of standard cost or market, which approximates actual cost. Cost is determined using the first-in, first-out method. Inventory is comprised of filled cylinders of MagneGas and accessories (regulators and tips) available for sale and accumulated costs incurred in the manufacturing process of units held for future sales.
	The Company is manufacturing additional units for sale. Each unit is assigned a project number and the costs, including labor, are accumulated in the carrying value as inventory. Upon delivery, the accumulated cost for the unit will be charged to cost of sales. Units are reclassified to capitalized assets when shipped to location for the production of metal cutting gas for the purpose of resale.
	Long-Lived Assets
	Property and equipment is stated at cost. Depreciation is computed by the straight-line method over estimated useful lives (3-7 years). Intellectual property assets are stated at their fair value acquisition cost. Amortization of intellectual property assets is calculated by the straight line method over their estimated useful lives (15 years). Historical costs are reviewed and evaluated for their net realizable value of the assets. The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation and amortization period or the unamortized balance is warranted. Based upon its most recent analysis, the Company believes that no impairment of property and equipment existed at December 31, 2014.
	Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable. When required impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets. We did not recognize any impairment losses for any periods presented.
	Stock Based Compensation
	The Company issues restricted stock to consultants for various services Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. Stock compensation for the periods presented were issued to consultants for past services provided, accordingly, all shares issued are fully vested, and there is no unrecognized compensation associated with these transactions.
	Shipping Costs
	The Company includes shipping costs and freight-in costs in cost of goods sold. Total freight-in included in cost of goods sold expense was $223,938 and $36,304 for the years ended December 31, 2014 and 2013, respectively.
	Advertising Costs
	The costs of advertising are expensed as incurred. Advertising expenses are included in the Company’s operating expenses. Advertising expense was $59,946 and $116,260 for the years ended December 31, 2014 and 2013, respectively.
	Research and Development
	The Company expenses research and development costs when incurred. Research and development costs include engineering and laboratory testing of product and outputs.
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized.
	Earnings (Loss) Per Share
	Basic earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares outstanding during the year. Diluted earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares. The Company has issued options to several investors, upon their purchase of shares. Options, whose strike price is less than the current market value, are considered common stock equivalents and are included in dilutive earnings per share.
			December 31,
			2014			2013
	Net Income (Loss)		$	-7,152,452		$	-6,318,724
	Weighted Average Shares
	Common Stock			-0.23			-0.29
	Common stock equivalents (Options)			-0.23	*		-0.29
	* Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Recently_Issued_Accounting_Pro

Recently Issued Accounting Pronouncements	12 Months Ended
	Dec. 31, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	3.                Recently Issued Accounting Pronouncements
	The Company reviews new accounting standards as issued. No new standards had any material effect on these financial statements. The accounting pronouncements issued subsequent to the date of these financial statements that were considered significant by management were evaluated for the potential effect on these consolidated financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these consolidated financial statements as presented and does not anticipate the need for any future restatement of these consolidated financial statements because of the retro-active application of any accounting pronouncements issued subsequent to December 31, 2011 through the date these financial statements were issued.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	4.                Inventory
	Inventory primarily consists of:
		December 31,
		2014		2013
	Metal cutting fuel	$	984,287	$	255,497
	Units for resale, Construction in process		1,180,551		1,454,569
		$	2,164,838	$	1,710,066

Long_Lived_Assets

Long Lived Assets	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	5.                Long Lived Assets
	Property and equipment consists of:
		December 31,
		2014		2013
	Machinery and equipment	$	273,450	$	230,563
	Furniture and office equipment		63,461		52,115
	Transportation		275,210		211,908
	Production units & cylinders		4,292,959		3,935,020
	Land and buildings		2,420,124		1,517,672
			7,315,175		5,967,896
	Less accumulated depreciation		961,520		661,744
		$	6,353,655	$	5,306,152
	Depreciation of fixed assets was $328,172 and $387,972 for the years ended December 31, 2014 and 2013, respectively.
	Intellectual property:
	The Company owns intellectual property, which it is amortizing on a straight-line basis over the assets useful life. The Company assesses fair market value for any impairment to the carrying values. As of December 31, 2014 management concluded that there was no impairment to the intangible assets.
		December 31,
		2014		2013
	Intellectual property	$	789,166	$	731,270
	Less accumulated amortization		296,914		248,446
		$	492,252	$	482,824
	Future amortization through December 31,:
	2015	$	48,467
	2016		48,467
	2017		48,467
	2018		48,467
	2019		48,467
	2020 and thereafter		249,917
		$	492,252
	Amortization of the intangible assets was $48,468 and $48,468 for the years ended December 31, 2014 and 2013, respectively.
	Management periodically reviews the valuation of this asset for potential impairments. Consideration of various risks to the valuation and potential impairment includes, but is not limited to:(a) the technology’s acceptance in the marketplace and our ability to attain projected forecasts of revenue (discounted cash flow of projections); (b) competition of alternative solutions; and (c) federal and state laws which may prohibit the use of our production machinery as currently designed. Management has not impaired this asset, to date, and does not anticipate any negative impact from known current business developments. Management continuously measures the marketplace, potential revenue developments and competitive developments in the scientific industry.

Investment_in_Joint_Ventures

Investment in Joint Ventures	12 Months Ended
	Dec. 31, 2014
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments and Joint Ventures Disclosure [Text Block]	6.                Investment in Joint Ventures
	On June 25, 2010, the Company entered into agreement with a Belgium company, whereby 250,000 shares of MagneGas Corporation’s common stock and territorial license rights were exchanged for a 20% interest in MagneGas Europe. The Company valued the investment in the Joint Venture at the fair market value of the shares issued ($23,750). The Company does not have effective or beneficial control over the European entity and is to account for the investment under the Equity Method. Current year activity for the joint venture was immaterial.
	On June 28, 2010, the Company entered into agreement with DDI Industries, a China company, in formation of MagneGas China. The Company is to provide mechanical drawings (for complete construction), computer programs, license of patents (Greater China Region), trademarks, etc. of the Plasma Arc Flow Recyclers to the new entity in exchange for a $2 million investment in MagneGas Corporation (received as of September 30, 2011; subscription at a share price of $0.135 or 14,814,814 common shares) and 20% share in MagneGas China. The Company’s investment has been valued at $466,660, a mutually agreed amount for the technology license. The MagneGas China entity has been funded in cash for an amount which reflects the intellectual property’s value. The Company does not have effective or beneficial control over the China entity and is to account for the investment under the Cost Method. Current year activity for the joint venture was immaterial.
	Our investments in joint ventures are considered as Level 3, as defined in FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820), and management considers alternative methods for valuing these investments to determine if there would be impairment to the current carrying value, currently our cost basis. As of December 31, 2011, management does not believe any impairment exists with regard to the investments in joint ventures.

Acquisition_of_Subsidiary

Acquisition of Subsidiary	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	7.                Acquisition of Subsidiary
	As previously reported, on October 10, 2014, MagneGas Corporation (the “Company”), signed a Stock Purchase Agreement (the “Agreement”) with the Robert A. Ficocelli Revocable Trust, Robert A Ficocelli and Stephen R. Homer (each, a Seller Party and together, the “Seller Parties”), the holders of all of the issued and outstanding capital stock (the “ESSI Shares”) of Equipment Sales and Service, Inc., a Florida corporation (“ESSI”), pursuant to which the Company agreed to purchase, and the Seller Party agreed to sell, all the ESSI Shares for a total purchase price of Three Million Dollars ($3,000,000).
	ESSI operates a business of sales and distribution of gases based from its headquarters in Pinellas Park, Florida.
	The closing of the Company’s purchase of the ESSI Shares occurred on October 27, 2014. Upon the closing of this transaction, the Company entered into a lease agreement for the premises at Pinellas Park, Florida that had served as ESSI’s corporate headquarters.
	The Company accounted for the assets, liabilities and ownership interests in accordance with the provisions of ASC 805, Business Combinations for acquisitions occurring in years beginning after December 15, 2008 (formerly SFAS No. 141R, Business Combinations). As such, the recorded assets and liabilities acquired were recorded at fair value and any difference in the net asset values and the consideration given will be recorded as a gain on acquisition or as goodwill. The pro forma consolidated balance sheet as of September 30, 2014 and consolidated statement of operations for the nine months then ended for the consolidated entity as if the acquisition had occurred on January 1, 2014 is as follows.
	The pro forma results disclosed in the tables below are based on annual statements of the Company and ESSI. Various assumptions were made and are not necessarily indicative of the results of operations that would have occurred had the Company completed this acquisition on January 1, 2013.
	The assets and liabilities acquired as of October 27, 2014 are as follows:
	Cash	$	53,216
	Accounts receivable		134,201
	Inventory		337,000
	™		390,500
	Goodwill		2,098,069
	Other assets		45
	Liabilities		-13,031
		$	3,000,000
	Cash consideration	$	3,000,000
	The pro forma income statements for the combined Companies as if they were together since January 1, 2013 are as follows:
		2014		2013
	Revenues	$	2,652,353	$	3,017,526
	Net income	$	-6,978,378	$	-6,269,661
	EPS		-0.19		-0.27

Deferred_Revenue_and_Customer_

Deferred Revenue and Customer Deposits	12 Months Ended
	Dec. 31, 2014
Deferred Revenue And Customer Deposits [Abstract]
Deferred Revenue And Customer Deposits [Text Block]	8.                Deferred Revenue and Customer Deposits
	The Company has received deposits on production units and fees for exclusive territorial license. The Company has deferred the associated revenues until such time that production order is placed and produced (recognition under percentage of completion method) or through the passage of time (recognition over the life of the license term).
		December 31,		December 31,
		2014		2013
	China territory license, exclusive 5 year license, expiring June 28, 2015		466,660		466,660
	Installment Payments from Kazakhstan for Equipment Purchase		499,000		499,000
	South African deposit for future sale		10,000		0
			975,660		965,660
	Portion recognized		918,994		786,339
	Deferred revenue and customer deposits	$	56,666	$	179,339
	The amount recognized as revenue under licensing arrangements was, $93,332 and $93,332 for years ended December 31, 2014 and 2013, respectively.

Income_Tax

Income Tax	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	9.                Income Tax
	Provision (Benefit) for Income Taxes
	The Company has not recognized a provision for income tax benefit during the periods presented, due to the net operating losses incurred. The Company may recognize benefits in future periods when management believes that any benefit will be recognized.
	Deferred Income Taxes
	Deferred income taxes are the result of timing differences between book and tax basis of certain assets and liabilities, timing of income and expense recognition of certain items and net operating loss carry-forwards.
	The Company assesses temporary differences resulting from different treatments of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are recorded in our balance sheets. The Company evaluates the reliability of its deferred tax assets and assesses the need for a valuation allowance on an ongoing basis. In evaluating its deferred tax assets, the Company considers whether it is more likely than not that the deferred income tax assets will be realized. The ultimate realization of deferred tax assets depends upon generating sufficient future taxable income prior to the expiration of the tax attributes. In assessing the need for a valuation allowance the Company must project future levels of taxable income. This assessment requires significant judgment. The Company examined the evidence related to a recent history of tax losses, the economic conditions in which it operates recent organizational changes, its forecasts and projections. The Company will continue to evaluate its deferred tax assets to determine whether any changes in circumstances could affect the realization of their future benefit.
	The Company had not previously recognized an income tax benefit for its operating losses generated since inception through December 31, 2009 based on uncertainties concerning its ability to generate taxable income in future periods of which, at the time, the realization could not be considered more likely than not. Based on events subsequent to the balance sheet date, management has re-assessed the valuation allowance and the recognition of its deferred tax losses, however, based on the Company’s history of losses and other negative evidence resulting in the allowance, no income tax benefit will be recognized for prior periods. The tax benefit for the prior periods, in the amount of $348,800, arising from operating losses as a start-up company and other temporary differences, has been off-set by an equal valuation allowance.
	Under the Internal Revenue Code of 1986, as amended, these losses can be carried forward twenty years. As of December 31, 2013 the Company has net operating loss carry forwards remaining from the following years:
		Net
		Operating		Year
	Year Generated	Loss		Expires
	2007-2014 approx	$	25,026,411		By 2033
	The adoption of provisions, required by Accounting Standard Codification (“ASC”) No. 740, did not result in any adjustments.
	The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending December 31, 2008 through 2014. The Company state income tax returns are open to audit under the statute of limitations for the years ending December 31, 2006 through 2014.  The Company’s 2012 tax return was audited in 2014 by the IRS and while certain deductions were disallowed in 2012 for tax purposes they were only timing differences so not penalties or interest were imposed due to that audit
	The Company recognizes interest and penalties related to income taxes in income tax expense. The Company had incurred no penalties and interest for the years ended December 31, 2014 and December 31, 2013.

Equity

Equity	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	10.              Equity
	The Company has three classifications of stock:
	Our certificate of incorporation provides that we are authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 per share. Our board of directors has the authority, without further action by the stockholders, to issue from time to time the preferred stock in one or more series for such consideration and with such relative rights, privileges, preferences and restrictions that the board may determine. The preferences, powers, rights and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and purchase funds and other matters. The issuance of preferred stock could adversely affect the voting power or other rights of the holders of common stock.
	Of the 10,000,000 shares authorized of Preferred stock at a par value of $0.001, 1,000,000 shares and 2,141.1328 shares of preferred stock have been designated and issued as Series A Preferred Stock and Series B Convertible Preferred Stock, respectively.
	Series A Preferred Stock has liquidation and dividend rights over Common Stock, which is not in excess of its par value. The preferred stock has no conversion rights or mandatory redemption features. There have been 1,000,000 shares of Preferred Stock issued to an entity controlled by Dr. Ruggero Santilli, Ermanno Santilli, President and CEO, Luisa Ingargiola, CFO and Carla Santilli, Director. Ermanno Santilli and Luisa Ingargiola have no equity interest, only voting control. Each share of Preferred Stock is entitled to 100,000 votes.
	Series B Preferred Stock has a liquidation preference equal to the stated value of each share of Series B Preferred Stock or $1,000 per share. The shares of Series B Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the Series B Preferred Stock. Subject to certain ownership limitations as described below, shares of Series B Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $0.80 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below $0.80. Subject to limited exceptions, holders of shares of Series B Preferred Stock will not have the right to convert any portion of their Preferred Stock if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion.
	Shares of Series C Preferred Stock have a liquidation preference equal to the stated value of each share of Preferred Stock or $1,000 per share. The shares of Series C Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the Series C Preferred Stock. Subject to certain ownership limitations as described below, shares of Series C Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $1.45 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of Series C Preferred Stock will not have the right to convert any portion of their Series C Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the Series C Preferred Stock or exercise of the March Investor Warrant, a number of shares of common stock which, when aggregated with the March Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction.
	Shares of Series D-1 Preferred Stock have a liquidation preference equal to the stated value of each share of October Preferred Stock or $1,000 per share. The shares of October Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the October Preferred Stock. Subject to certain ownership limitations as described below, shares of October Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $1.00 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of October Preferred Stock will not have the right to convert any portion of their October Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the October Preferred Stock or exercise of the October Investor Warrant, a number of shares of common stock which, when aggregated with the October Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction.
	The October Registered Stock was offered by the Company pursuant to the Registration Statement. On October 22, 2014, we filed a prospectus supplement with the SEC in connection with the sale of the October Registered Stock.
	The Series D-2 Private Placement Preferred Shares and October Investor Warrant were issued and sold without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder and in reliance on similar exemptions under applicable state laws. Accordingly, the Investor may convert the Series D-2 Private Placement Preferred Shares and exercise the October Investor Warrant and sell the underlying shares only pursuant to an effective registration statement under the Securities Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another applicable exemption under the Securities Act. Pursuant to a Registration Rights Agreement, dated October 21, 2014, by and between the Company and the October Investor (the “October Registration Rights Agreement”), the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock issuable upon conversion of the Series D-2 Private Placement Preferred Shares and upon exercise of the October Investor Warrant. This prospectus forms a part of the initial registration statement with the SEC covering the resale of the shares of common stock issuable upon conversion of the Series D-2 Private Placement Preferred Shares and upon exercise of the October Investor Warrant.
	The holders of Common Stock and the equivalent Series A Preferred Stock, voting together, shall appoint the members of the Board of the Directors. Each share of Common Stock is entitled to one vote.
	Common Stock includes 90,000,000 shares authorized at a par value of $0.001.
	Reverse Stock Split
	On June 26, 2012 we effected a ten-for-one reverse split of common shares. All share amounts have been retroactively adjusted to reflect the post-split shares
	Common Stock Issuances
	Prior to this Offering, the Company and the Investor did have a material relationship. In June 2010, the Company entered into an agreement with the Investor to form a Chinese joint venture (“MagneGas China”). Pursuant to the agreement, the Investor acquired exclusive MagneGas™ Technology and manufacturing rights for the Greater China Market. The Investor also acquired 1,481,482 shares of the Company’s common stock at a purchase price of $2 million and purchased a 300Kw Plasma Arc Refinery at a purchase price of $1.855 million. The Company owns 20% of the equity in MagneGas China and the Company’s former Chief Executive Officer, Dr. Ruggero Santilli, is a member of the board of directors. The Company is working with MagneGas China to replace Dr. Ruggero Santilli with Ermanno Santilli in this position. Pursuant to the agreement, the Company appointed Allen Feng, the Chief Executive Officer of the Investor, to its board of directors.
	On June 5, 2013, the Company closed its previously-announced underwritten public offering of 2,728,139 shares of common stock, par value $0.001 per share, and 2,728,139 warrants to purchase 682,035 shares of common stock with an exercise price of $1.35 per share, which includes the full exercise of the over-allotment option by the underwriter to purchase an additional 355,844 shares of common stock and warrants to purchase 88,961 shares of common stock with an exercise price of $1.35, at a combined price to the public of $0.90, for gross proceeds to the company of $2,455,325. The Company intends to use the proceeds from the offering for working capital and general corporate purposes. Northland Securities, Inc. acted as underwriter for the offering.
	On September 27, 2013, the company settled a dispute with GreenPlanet Aid C. V. of Mexico (GreenPlanet)to which GreenPlanet was requesting a refund of a non-refundable deposit and as settlement of this dispute the Company offered 93,750 shares of common stock. This resulted in a $43,750 gain which is recognized as Other Income. This is an unrelated entity to Clear Sky Energy S. A. de C. V. of Mexico, who has a current active contract with the Company.
	January 2014 Public and Private Offering
	On January 21, 2014, the Company entered into the Purchase Agreement with the Investor providing for the issuance and sale by the Company (the “Offering”) of 2,323,584 shares of the Company’s common stock, par value $0.001 per share, for a purchase price of $1,858,867.20 (the “Registered Stock”) and 2,141.13280 shares of the Company's Series B Preferred Stock, which are convertible into a total of 2,676,416 shares of common stock (the “Conversion Shares”). In connection with the purchase of shares of Series B Preferred Stock in the Offering, the Investor received warrants to purchase 2,676,416 shares of common stock at an exercise price equal to $1.11 (the “Warrants”). Each Warrant shall be initially exercisable on the six (6) month anniversary of the issuance date and have a term of exercise equal to five (5) years from the date on which first exercisable. The closing of the sale of these securities took place on January 27, 2014 (the “Closing”). The Company intends to use the proceeds from the offering for working capital and general corporate purposes. Northland Securities, Inc. acted as the placement agent for the offering
	March 2014 Financing
	On March 24, 2014, the Company entered into a Securities Purchase Agreement with an institutional investor (the “March Investor”) providing for the issuance and sale by the Company (the “March Offering”) of 2,000,000 shares (the “March Shares”) of the Company’s common stock, par value $0.001 per share, and 2,100.5 shares of the Company's Series C convertible preferred stock (the “Series C Preferred Stock”) which are convertible into a total of 1,448,276 shares of common stock (the “March Conversion Shares”) for an aggregate purchase price of $5,000,000 (the March Shares, the Series C Preferred Stock and the March Conversion Shares shall be referred to as the “March Registered Stock”). In connection with the purchase of shares of the March Registered Stock in the March Offering, the March Investor received a warrant to purchase 1,724,138 shares of common stock at an exercise price equal to $2.15 (the “March Investor Warrant”). The March Investor Warrant was initially exercisable on the six (6) month anniversary of the issuance date and has a term of exercise equal to five (5) years from the date on which first exercisable. The closing of the sale of these securities occurred on March 28, 2014.
	Shares of Series C Preferred Stock have a liquidation preference equal to the stated value of each share of Preferred Stock or $1,000 per share. The shares of Series C Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the Series C Preferred Stock. Subject to certain ownership limitations as described below, shares of Series C Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $1.45 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of Series C Preferred Stock will not have the right to convert any portion of their Series C Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the Series C Preferred Stock or exercise of the March Investor Warrant, a number of shares of common stock which, when aggregated with the March Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction.
	The March Registered Stock was offered by the Company pursuant to an effective shelf registration statement on Form S-3, which was initially filed with the Securities and Exchange Commission (the “SEC”) on May 17, 2013 and declared effective on May 28, 2013 (File No. 333-188661) (the “Registration Statement”). On March 27, 2014, we filed a prospectus supplement with the SEC in connection with the sale of the March Registered Stock.
	The March Investor Warrant was issued and sold without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder and in reliance on similar exemptions under applicable state laws. All potential investors in the March Offering, including the private placement, were solicited by means of direct contact by Northland Securities, Inc. (the “Placement Agent”). The Placement Agent had a substantive pre-existing relationship with the institutional investor and the Company did not engage in any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) in connection with the offer or sale of the Series C Preferred Stock or the March Investor Warrant. Accordingly, the March Investor may exercise the warrant and sell the underlying shares only pursuant to an effective registration statement under the Securities Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another applicable exemption under the Securities Act. Pursuant to a Registration Rights Agreement, dated March 24, 2014, by and between the Company and the Investor (the “March Registration Rights Agreement”), the Company agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock issuable upon exercise of the March Investor Warrant. This prospectus forms a part of the initial registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the March Investor Warrant.
	Moreover, in connection with the March Offering the Placement Agent received cash compensation equal to 7% of the total amount raised and received a warrant to purchase an aggregate amount of 172,414 shares of the Company’s common stock (“March Agent Warrant”). This prospectus forms a part of the initial registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the March Agent Warrant.
	October 2014 Financing
	On October 21, 2014, the Company entered into a Securities Purchase Agreement (the “October Purchase Agreement”) with an institutional investor (the “October Investor”) providing for the issuance and sale by the Company (the “October Offering”) of 3,000,000 shares of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.00 per share (the “October Common Shares”), 1,060 shares of the Company's Series D-1 convertible preferred stock, par value $0.001 per share, at a purchase price of $1,000 per share (the “Series D-1 Preferred Shares”), which are convertible into a total of 1,060,000 shares of common stock for an aggregate purchase price of $4,060,000 (the October Common Shares, and Series D-1 Preferred Shares shall be referred to as the “October Registered Stock”). Pursuant to the October Purchase Agreement, the October Investor also agreed to purchase 940 shares the Company’s Series D-2 convertible preferred stock, par value $0.001 per share, at a purchase price of $1,000 per share, in a private placement (the “Series D-2 Private Placement Preferred Shares,” together with the Series D-1 Preferred Shares, the “October Preferred Stock”), which are convertible into a total of 940,000 shares of the Company’s Common Stock for an aggregate purchase price of $940,000. In connection with the purchase of the Series D-2 Private Placement Preferred Shares, the October Investor received a warrant to purchase 5,000,000 shares of the Company’s common stock at an exercise price equal to $1.31 (the “October Investor Warrant”). The October Investor Warrant shall be initially exercisable on the six (6) month anniversary of the issuance date and have a term of exercise equal to five (5) years from the date on which first exercisable. The closing of the sale of these securities occurred on October 23, 2014.
	Shares of Series D-1 Preferred Stock have a liquidation preference equal to the stated value of each share of October Preferred Stock or $1,000 per share. The shares of October Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the October Preferred Stock. Subject to certain ownership limitations as described below, shares of October Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $1.00 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of October Preferred Stock will not have the right to convert any portion of their October Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the October Preferred Stock or exercise of the October Investor Warrant, a number of shares of common stock which, when aggregated with the October Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction.
	The October Registered Stock was offered by the Company pursuant to the Registration Statement. On October 22, 2014, we filed a prospectus supplement with the SEC in connection with the sale of the October Registered Stock.
	The Series D-2 Private Placement Preferred Shares and October Investor Warrant were issued and sold without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder and in reliance on similar exemptions under applicable state laws. Accordingly, the Investor may convert the Series D-2 Private Placement Preferred Shares and exercise the October Investor Warrant and sell the underlying shares only pursuant to an effective registration statement under the Securities Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another applicable exemption under the Securities Act. Pursuant to a Registration Rights Agreement, dated October 21, 2014, by and between the Company and the October Investor (the “October Registration Rights Agreement”), the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock issuable upon conversion of the Series D-2 Private Placement Preferred Shares and upon exercise of the October Investor Warrant. This prospectus forms a part of the initial registration statement with the SEC covering the resale of the shares of common stock issuable upon conversion of the Series D-2 Private Placement Preferred Shares and upon exercise of the October Investor Warrant.
	Moreover, in connection with the October Offering the Placement Agent received cash compensation equal to 7% of the total amount raised and received a warrant to purchase an aggregate amount of 250,000 shares of the Company’s common stock (“October Agent Warrant”). This prospectus forms a part of the initial registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the October Agent Warrant
	During 2014, the company issued 1,284,937 shares of Common Stock as payments for services, investment, or exchange.
	Options and Warrants
	On March 31, 2012 the Company issued 2,910,000 options to executives, in connection with employment agreements, at an exercise price of $1.50, vesting over a 3 year period. The Company calculated the value of these shares at $3,921,900, based on using Black-Sholes model. Assumptions used in the calculation were: volatility of 31.6%; estimated life of 2.5 years; 0% forfeiture; and risk free interest rate of 39%. The Company recognized stock-based compensation, on a straight-line basis over the ratable vesting period, in the amount of $1,465,888 for the year ended December 31, 2013.
	During the nine month period ended September 30, 2012, in association with the private placement stated above, there were 1,067,687 warrants issued with the $3,882,500 raise. These warrants are for a five year period with an exercise price of $4.00 per share.
	During the nine month period ended September 30, 2013, in association with the public offering stated above, there were 770,996 warrants issued with the $2,455,325 raise. These warrants are for a 5 year period with an exercise price of $1.35 per share.
	The following is a summary of outstanding options and warrants:
						Weighted Average
		Options		Options		Intrinsic		Exercise		Remaining
		Outstanding		Vested		Value		Price		Term
	31-Dec-12		5,973,125		3,315,625						1.2
	Granted		1,485,996				0.95		0.88
	Exercised
	Forfeited		550,000
	31-Dec-13		6,909,121		4,553,922	$	2.44	$	1.43		13.6
	Granted		11,475,554		437,500		1.51		1.48
	Exercised		-675,000		-75,000
	Forfeited		-1,550,000		-1,698,922
	31-Dec-14		16,159,675		3,217,500	$	2.27	$	1.41		2.8 year

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	11.              Related Party Transactions
	In February 2008, we entered into a five-year consulting agreement with Dr. Santilli, whose knowledge and expertise of the technology is essential in the development of the MagneGas product. The terms of the consulting agreement consist of issuance of common stock (10,000 shares) and payment of $5,000 per month to Dr. Santilli, upon the determination by the board of directors of MagneGas Corporation of achieving adequate funding. The board of directors has since determined that Dr. Santilli’s consulting agreement would be replaced with an employment agreement with a monthly salary of$15,000 per month. On April 30, 2013, Dr. Santilli resigned and payments ceased.
	Beginning in April 2008, we entered into a month-to-month lease, at a monthly rate of $2,500 per month for facilities to occupy approximately 3,000 square feet of a 6,000 square foot building and the use of certain equipment and utilities, as needed. In January 2011, the Company expanded to occupy 5,000 square feet of the building and as a result, the rent was increased to $4,000 per month. The facility allows for expansion needs. The lease is held by EcoPlus, Inc., a company that is effectively controlled by Dr. Santilli.
	On June, 25, 2010, we entered into an agreement to acquire a 20% ownership of MagneGas Europe (MagneGas Arc Applied Solutions, Belgium). In exchange, we issued to MagneGas Arc Applied Solutions 25,000 shares of common shares, which were valued at the fair market price at the date of grant, June 25, 2010, at $0.95 per share for an aggregate of $23,750. Dr. Santilli and Ermanno Santilli are stockholders of MagneGas Arc Applied Solutions, and at the time of the agreement, Ermanno Santilli, our current Chief Executive Officer, was the Chief Executive Officer of MagneGas Arc Applied Solutions and Vice President of MagneGas Corporation.
	Employment Agreements
	The employment agreement for Ermanno Santilli expired March 31, 2014 and the Board of Directors is currently negotiating an extension of this contract. Effective January 1, 2015, his annual salary was increased to $130,000 per year plus bonus to be determined by the Board based on performance.
	The employment agreement for Luisa Ingargiola expired March 31, 2014 and the Board of Directors is currently negotiating an extension of this contract. Effective January 1, 2015, her annual salary was increased to $120,000 per year plus bonus to be determined by the Board based on performance.
	Director Compensation
	The MagneGas independent board members receive $20,000 each in quarterly compensation for their services rendered on the Board of Directors. This compensation was paid in the form of common stock equivalent shares, calculated based on the average common share price during the last 10 business days of each quarter.

Product_Line_Information

Product Line Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	12.              Product Line Information
	The following information is the results of our operating Product Line Revenues :
		Revenue		Costs		Margin
	31-Dec-13
	Segments:
	Unit Sales	$	459,659	$	203,551	$	256,108
	License Fees		93,332		-		93,332
	Metal Cutting		435,995		344,927		91,068
		$	988,986	$	548,478	$	440,508
	31-Dec-14
	Segments:
	Unit Sales	$	54,341	$	64,983	$	-10,642
	License Fees		93,332		-		93,332
	Metal Cutting		875,373		608,884		266,489
		$	1,023,046	$	673,867	$	349,179

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Contingencies Disclosure [Text Block]		13	Contingencies
	From time to time the Company may be a party to litigation matters involving claims against the Company. The Company operates with waste, hazardous material and within a highly regulated industry, which may lend itself to legal matters. Management believes that there are no current matters that would have a material effect on the Company’s financial position or results of operations.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	14.              Subsequent events
	January 14, 2015,the Company entered into a Commercial Agreement to sell its facility located at 1500 Rainville Road, Tarpon Springs, FL 34689 for $675,000.
	On February 27, the Company and the Buyer entered into an addendum to the Agreement whereby the parties agreed, among other items, to lower the purchase price to $450,000. The parties agreed to this lower price due to improvements that need to be made to the facility that were discovered during the due diligence period. The closing date is March 31, 2015.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The financial statements presented include estimates for patent life, recoverability of deferred tax assets and collections on our receivables. Our estimates include consideration of the useful lives of our intellectual property, allocations to research and development costs and recognition of deferred tax assets.
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable Interest Entities
	The Company considers the consolidation of entities to which the usual condition (ownership of a majority voting interest) of consolidation does not apply, focusing on controlling financial interests that may be achieved through arrangements that do not involve voting interest. If an enterprise holds a majority of the variable interests of an entity, it would be considered the primary beneficiary. The primary beneficiary is generally required to consolidate assets, liabilities and non-controlling interests at fair value (or at historical cost if the entity is a related party) and subsequently account for the variable interest as if it were consolidated based on a majority voting interest. The Company has investments in joint ventures that are in development of the MagneGas technology, however the Company is not identified as a primary beneficiary; therefore no consolidation is required and the investments are listed at their cost.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
	⋅	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
	⋅	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e. g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	⋅	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.
	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.
	The Company applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	The majority of cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. At December 31, 2014, nothing exceeded the Federal Deposit Insurance Corporation (FDIC) limits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable, Credit
	Accounts receivable consist of amounts due for the delivery of MagneGas sales to customers. An allowance for doubtful accounts is considered to be established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, and current economic trends. Based on management’s review of accounts receivable, allowances for doubtful accounts were established as deemed necessary. Receivables are determined to be past due, based on payment terms of original invoices. Reserves for uncollectible accounts were $104,028 for 2014 as compared to $83,069 in 2013. The Company does not typically charge interest on past due receivables.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	The Company generates revenue through two processes: (1) Sale of MagneGas fuel for metal cutting and (2) Sale of its Plasma Arc Flow units. Additionally we also recognize revenue from territorial license arrangements.
	⋅	Revenue for metalworking fuel is recognized when shipments are made to customers. The Company recognizes a sale when the product has been shipped and risk of loss has passed to the customer.
	⋅	Revenue generated from sales of its production unit is recognized on a percentage of completion, based on the progress during manufacturing of the unit. Our machine is a significant investment and generally requires a 6 to 9 month production cycle. During the course of building a unit the actual costs are tracked to our cost estimates and revenue is proportionately recognized during the process. Significant deposits are required before production. These deposits are classified as customer deposits.
	⋅	Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories. We recognize revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement.
Inventory, Policy [Policy Text Block]	Inventories
	Inventories are stated at the lower of standard cost or market, which approximates actual cost. Cost is determined using the first-in, first-out method. Inventory is comprised of filled cylinders of MagneGas and accessories (regulators and tips) available for sale and accumulated costs incurred in the manufacturing process of units held for future sales.
	The Company is manufacturing additional units for sale. Each unit is assigned a project number and the costs, including labor, are accumulated in the carrying value as inventory. Upon delivery, the accumulated cost for the unit will be charged to cost of sales. Units are reclassified to capitalized assets when shipped to location for the production of metal cutting gas for the purpose of resale.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets
	Property and equipment is stated at cost. Depreciation is computed by the straight-line method over estimated useful lives (3-7 years). Intellectual property assets are stated at their fair value acquisition cost. Amortization of intellectual property assets is calculated by the straight line method over their estimated useful lives (15 years). Historical costs are reviewed and evaluated for their net realizable value of the assets. The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation and amortization period or the unamortized balance is warranted. Based upon its most recent analysis, the Company believes that no impairment of property and equipment existed at December 31, 2014.
	Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable. When required impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets. We did not recognize any impairment losses for any periods presented.
Compensation Related Costs, Policy [Policy Text Block]	Stock Based Compensation
	The Company issues restricted stock to consultants for various services Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. Stock compensation for the periods presented were issued to consultants for past services provided, accordingly, all shares issued are fully vested, and there is no unrecognized compensation associated with these transactions.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping Costs
	The Company includes shipping costs and freight-in costs in cost of goods sold. Total freight-in included in cost of goods sold expense was $223,938 and $36,304 for the years ended December 31, 2014 and 2013, respectively.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs
	The costs of advertising are expensed as incurred. Advertising expenses are included in the Company’s operating expenses. Advertising expense was $59,946 and $116,260 for the years ended December 31, 2014 and 2013, respectively.
Research and Development Expense, Policy [Policy Text Block]	Research and Development
	The Company expenses research and development costs when incurred. Research and development costs include engineering and laboratory testing of product and outputs.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) Per Share
	Basic earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares outstanding during the year. Diluted earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares. The Company has issued options to several investors, upon their purchase of shares. Options, whose strike price is less than the current market value, are considered common stock equivalents and are included in dilutive earnings per share.
			December 31,
			2014			2013
	Net Income (Loss)		$	-7,152,452		$	-6,318,724
	Weighted Average Shares
	Common Stock			-0.23			-0.29
	Common stock equivalents (Options)			-0.23	*		-0.29
	* Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Dilutive earnings per share(Table Text Block)		December 31,
		2014			2013
	Net Income (Loss)	$	-7,152,452		$	-6,318,724
	Weighted Average Shares
	Common Stock		-0.23			-0.29
	Common stock equivalents (Options)		-0.23	*		-0.29
	* Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Inventory_Tables

Inventory (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory primarily consists of:
		December 31,
		2014		2013
	Metal cutting fuel	$	984,287	$	255,497
	Units for resale, Construction in process		1,180,551		1,454,569
		$	2,164,838	$	1,710,066

Long_Lived_Assets_Tables

Long Lived Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment consists of:
		December 31,
		2014		2013
	Machinery and equipment	$	273,450	$	230,563
	Furniture and office equipment		63,461		52,115
	Transportation		275,210		211,908
	Production units & cylinders		4,292,959		3,935,020
	Land and buildings		2,420,124		1,517,672
			7,315,175		5,967,896
	Less accumulated depreciation		961,520		661,744
		$	6,353,655	$	5,306,152
Schedule of Finite-Lived Intangible Assets [Table Text Block]	As of December 31, 2014 management concluded that there was no impairment to the intangible assets.
		December 31,
		2014		2013
	Intellectual property	$	789,166	$	731,270
	Less accumulated amortization		296,914		248,446
		$	492,252	$	482,824
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Future amortization through December 31,:
	2015	$	48,467
	2016		48,467
	2017		48,467
	2018		48,467
	2019		48,467
	2020 and thereafter		249,917
		$	492,252

Acquisition_of_Subsidiary_Tabl

Acquisition of Subsidiary (Tables)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The assets and liabilities acquired as of October 27, 2014 are as follows:
	Cash	$	53,216
	Accounts receivable		134,201
	Inventory		337,000
	™		390,500
	Goodwill		2,098,069
	Other assets		45
	Liabilities		-13,031
		$	3,000,000
	Cash consideration	$	3,000,000
Business Acquisition, Pro Forma Information [Table Text Block]	The pro forma income statements for the combined Companies as if they were together since January 1, 2013 are as follows:
		2014		2013
	Revenues	$	2,652,353	$	3,017,526
	Net income	$	-6,978,378	$	-6,269,661
	EPS		-0.19		-0.27

Deferred_Revenue_and_Customer_1

Deferred Revenue and Customer Deposits (Tables)	12 Months Ended
	Dec. 31, 2014
Deferred Revenue And Customer Deposits [Abstract]
Deferred Revenue And Customer Deposits [Table Text Block]	The Company has deferred the associated revenues until such time that production order is placed and produced (recognition under percentage of completion method) or through the passage of time (recognition over the life of the license term).
		December 31,		December 31,
		2014		2013
	China territory license, exclusive 5 year license, expiring June 28, 2015		466,660		466,660
	Installment Payments from Kazakhstan for Equipment Purchase		499,000		499,000
	South African deposit for future sale		10,000		0
			975,660		965,660
	Portion recognized		918,994		786,339
	Deferred revenue and customer deposits	$	56,666	$	179,339

Income_Tax_Tables

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Summary of Operating Loss Carryforwards [Table Text Block]	As of December 31, 2013 the Company has net operating loss carry forwards remaining from the following years:
		Net
		Operating		Year
	Year Generated	Loss		Expires
	2007-2014 approx	$	25,026,411		By 2033

Equity_Tables

Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	The following is a summary of outstanding options and warrants:
						Weighted Average
		Options		Options		Intrinsic		Exercise		Remaining
		Outstanding		Vested		Value		Price		Term
	31-Dec-12		5,973,125		3,315,625						1.2
	Granted		1,485,996				0.95		0.88
	Exercised
	Forfeited		550,000
	31-Dec-13		6,909,121		4,553,922	$	2.44	$	1.43		13.6
	Granted		11,475,554		437,500		1.51		1.48
	Exercised		-675,000		-75,000
	Forfeited		-1,550,000		-1,698,922
	31-Dec-14		16,159,675		3,217,500	$	2.27	$	1.41		2.8 year

Product_Line_Information_Table

Product Line Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	The following information is the results of our operating Product Line Revenues :
		Revenue		Costs		Margin
	31-Dec-13
	Segments:
	Unit Sales	$	459,659	$	203,551	$	256,108
	License Fees		93,332		-		93,332
	Metal Cutting		435,995		344,927		91,068
		$	988,986	$	548,478	$	440,508
	31-Dec-14
	Segments:
	Unit Sales	$	54,341	$	64,983	$	-10,642
	License Fees		93,332		-		93,332
	Metal Cutting		875,373		608,884		266,489
		$	1,023,046	$	673,867	$	349,179

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Summary of Dilutive earnings per share[Line Items]
Net income (loss)	($7,152,452)		($6,318,724)
Earnings Per Share, Diluted	($0.23)		($0.29)
Common Stock [Member]
Summary of Dilutive earnings per share[Line Items]
Earnings Per Share, Diluted	($0.23)		($0.29)
Common Stock Equivalents Options [Member]
Summary of Dilutive earnings per share[Line Items]
Earnings Per Share, Diluted	($0.23)	[1]	($0.29)
[1]	Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Specific life for intellectual property	15 years
Shipping Costs	$223,938	$36,304
Advertising Expense	59,946	116,260
Allowance for Doubtful Accounts Receivable	$104,028	$83,069
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Production cycle of the machine	9 months
Estimated useful lives	7 years
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Production cycle of the machine	6 months
Estimated useful lives	3 years

Inventory_Details

Inventory (Details ) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventory [Line Items]
Metal cutting fuel	$984,287	$255,497
Units for resale, Construction in process	1,180,551	1,454,569
Total inventory	$2,164,838	$1,710,066

Long_Lived_Assets_Details

Long Lived Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$7,315,175	$5,967,896
Less accumulated depreciation	961,520	661,744
Property, Plant and Equipment, Net	6,353,655	5,306,152
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	273,450	230,563
Furniture And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	63,461	52,115
Transportation [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	275,210	211,908
Production Units And Cylinders [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	4,292,959	3,935,020
Land and Buildings [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$2,420,124	$1,517,672

Long_Lived_Assets_Details_1

Long Lived Assets (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Intellectual property	$789,166	$731,270
Less accumulated amortization	296,914	248,446
Finite-Lived Intangible Assets, Net	$492,252	$482,824

Long_Lived_Assets_Details_2

Long Lived Assets (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
2015	$48,467
2016	48,467
2017	48,467
2018	48,467
2019	48,467
2020 and thereafter	249,917
Finite-Lived Intangible Assets, Net	$492,252	$482,824

Long_Lived_Assets_Details_Text

Long Lived Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation	$328,172	$387,972
Amortization of Intangible Assets	$48,468	$48,468

Investment_in_Joint_Ventures_D

Investment in Joint Ventures (Details Textual) (USD $)	Jun. 28, 2010	Jun. 25, 2010
Schedule of Equity Method Investments [Line Items]
MagneGas Corporation's common stock exchanged to purchase the interest in MagneGas Europe		250,000
Ownership interest		20.00%
Company valued the investment in the Joint Venture at the fair market value of the shares issued		($23,750)
Agreement's exchange price given to DDI industries	2,000,000
Share price of subscription	$0.14
Number of common shares given for subscription	14,814,814
Share of subsidiary given to party in addition to agreement exchange price	20.00%
Company's investment for technology license	$466,660

Acquisition_of_Subsidiary_Deta

Acquisition of Subsidiary (Details) (USD $)	1 Months Ended
	Oct. 27, 2014
Business Acquisition [Line Items]
Cash	$53,216
Accounts receivable	134,201
Inventory	337,000
TM	390,500
Goodwill	2,098,069
Other assets	45
Liabilities	-13,031
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	3,000,000
Cash consideration	$3,000,000

Acquisition_of_Subsidiary_Deta1

Acquisition of Subsidiary (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Revenues	$2,652,353	$3,017,526
Net income	($6,978,378)	($6,269,661)
EPS	($0.19)	($0.27)

Acquisition_of_Subsidiary_Deta2

Acquisition of Subsidiary (Details Textual) (USD $)	0 Months Ended	1 Months Ended
	Oct. 10, 2014	Oct. 27, 2014
Business Acquisition [Line Items]
Business Combination, Consideration Transferred	$3,000,000	$3,000,000

Deferred_Revenue_and_Customer_2

Deferred Revenue and Customer Deposits (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]
Deferred revenue and customer deposits, Gross	$975,660	$965,660
Portion recognized	918,994	786,339
Deferred revenue and customer deposits	56,666	179,339
China territory license, exclusive 5 year license, expiring June 28, 2015 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue and customer deposits, Gross	466,660	466,660
Installment payments from Kazakhstan for equipment [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue and customer deposits, Gross	499,000	499,000
South African Deposit For Future Sale [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue and customer deposits, Gross	$10,000	$0

Deferred_Revenue_and_Customer_3

Deferred Revenue and Customer Deposits (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]
Territory License Period	5 years
Territory License Expiration Date	6/28/15
Licenses Revenue	$93,332	$93,332

Income_Tax_Details

Income Tax (Details) (2007-2014 approx [Member], USD $)	12 Months Ended
	Dec. 31, 2014
2007-2014 approx [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$25,026,411
Operating Loss Carryforward Expiration Dates	2033

Income_Tax_Details_Textual

Income Tax (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014
Operating Loss Carryforwards [Line Items]
Income Tax Expense Benefit For Prior Periods	$348,800

Equity_Details

Equity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Summary Of Outstanding Options And Warrants [Line Items]
Options and warrants Granted, weighted average Intrinsic Value		$0.95
Option And Warrant [Member]
Summary Of Outstanding Options And Warrants [Line Items]
Options and warrants Outstanding, Beginning Balance	6,909,121	5,973,125
Options and warrants Outstanding, Granted	11,475,554	1,485,996
Options and warrants Outstanding, Exercised	-675,000
Options and warrants Outstanding, Forfeited	-1,550,000	550,000
Options and warrants Outstanding, Ending Balance	16,159,675	6,909,121	5,973,125
Options and warrants Vested, Beginning Balance	4,553,922	3,315,625
Options and warrants Vested, Granted	437,500
Options and warrants Vested, Exercised	-75,000
Options and warrants Vested, Forfeited	-1,698,922
Options and warrants Vested, Ending Balance	3,217,500	4,553,922	3,315,625
Options and warrants outstanding, weighted average Intrinsic Value	$2.44
Options and warrants Granted, weighted average Intrinsic Value	$1.51
Options and warrants outstanding, weighted average Intrinsic Value	$2.27	$2.44
Options and warrants outstanding, Weighted Average Exercise Price	$1.43
Options and warrants Granted, Weighted Average Exercise Price	$1.48	$0.88
Options and warrants outstanding, Weighted Average Exercise Price	$1.41	$1.43
Options and warrants outstanding, Weighted Average Remaining Term	2 years 9 months 18 days	13 years 7 months 6 days	1 year 2 months 12 days

Equity_Details_Textual

Equity (Details Textual) (USD $)

1 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

Mar. 31, 2012

Jun. 30, 2010

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2013

Mar. 24, 2014

Jan. 21, 2014

Oct. 21, 2014

Dec. 31, 2014

Sep. 27, 2013

Jun. 05, 2013

Jun. 28, 2010

Summary Of Outstanding Options And Warrants [Line Items]

Warrant Issued

1,067,687

770,996

Preferred Stock, Shares Authorized

10,000,000

10,000,000

Preferred Stock, Par or Stated Value Per Share

$0.00

0.001

Common Stock, Shares Authorized

900,000,000

900,000,000

Common Stock, Par or Stated Value Per Share

$0.00

0.001

Investment Warrants, Exercise Price

$4

$1.35

Preferred Stock, Shares Issued

1,002,000

1,002,000

Options Issued Strike Price

$1.50

Calculated Value Of Warrants Using Black Sholes Model

$3,921,900

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

2 years 6 months

Warrants Expiration Term

5 years

5 years

Number Of Options Issued

2,910,000

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

31.60%

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate

0.00%

Recognized Stock Based Compensation

1,465,888

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

3 years

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

39.00%

Share Price

$0.14

Common Stock Acquired In Joint Venture

1,481,482

Stock Issued During Period, Value, New Issues

2,511,576

Joint Venture Ownership Percentage

20.00%

Units Of Plasma Arc Purchased

300

Value Of Refinery

1,855,000

Proceeds from Issuance of Warrants

3,882,500

2,455,325

March Offering [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

172,414

Cash compensation Received By Placement Agent Percentage

7.00%

October Offering [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

250,000

Cash compensation Received By Placement Agent Percentage

7.00%

Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Common Stock Acquired In Joint Venture

1,724,138

2,676,416

Conversion of Stock, Shares Converted

1,448,276

2,676,416

Common Stock Value Acquired In Joint Venture

2,000,000

Warrants Exercisable Term

The March Investor Warrant was initially exercisable on the six (6) month anniversary of the issuance date and has a term of exercise equal to five (5) years from the date on which first exercisable

Each Warrant shall be initially exercisable on the six (6) month anniversary of the issuance date and have a term of exercise equal to five (5) years from the date on which first exercisable

October 2014 Financing [Member] | Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Common Stock, Par or Stated Value Per Share

$0.00

Share Price

$1

Conversion of Stock, Shares Issued

3,000,000

Series A Preferred Stock [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Preferred Stock, Voting Rights

Each share of Preferred Stock is entitled to 100,000 votes

Preferred Stock, Shares Issued

1,000,000

Series B Preferred Stock [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Conversion Price Of Preferred Stock

0.8

Preferred Stock, Shares Issued

21,411,328

Preferred Stock, Liquidation Preference Per Share

1,000

Conversion of Stock, Shares Converted

214,113,280

Convertible Preferred Stock, Terms of Conversion

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below $0.80. Subject to limited exceptions, holders of shares of Series B Preferred Stock will not have the right to convert any portion of their Preferred Stock if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Companys common stock outstanding immediately after giving effect to its conversion

Series B Preferred Stock [Member] | Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Common Stock, Par or Stated Value Per Share

0.001

Conversion of Stock, Shares Issued

2,323,584

Stock Issued During Period, Value, New Issues

1,858,867

Debt Instrument, Convertible, Conversion Price

1.11

Series C Preferred Stock [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Conversion Price Of Preferred Stock

1.45

1.45

Preferred Stock, Liquidation Preference Per Share

1,000

1,000

Conversion of Stock, Shares Converted

21,005

Convertible Preferred Stock, Terms of Conversion

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of Series C Preferred Stock will not have the right to convert any portion of their Series C Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Companys common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the Series C Preferred Stock or exercise of the March Investor Warrant, a number of shares of common stock which, when aggregated with the March Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction

Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Preferred Stock, Par or Stated Value Per Share

0.001

Conversion of Stock, Shares Converted

2,100.50

Conversion of Stock, Shares Issued

2,000,000

Debt Instrument, Convertible, Conversion Price

2.15

Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value

5,000,000

Series D-1 Preferred Stock [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Conversion Price Of Preferred Stock

$1

1

Preferred Stock, Liquidation Preference Per Share

$1,000

1,000

Convertible Preferred Stock, Terms of Conversion

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of October Preferred Stock will not have the right to convert any portion of their October Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Companys common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the October Preferred Stock or exercise of the October Investor Warrant, a number of shares of common stock which, when aggregated with the October Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. Subject to limited exceptions, holders of shares of October Preferred Stock will not have the right to convert any portion of their October Preferred Stock that would result in the holder, together with its affiliates, beneficially owning in excess of 9.99% of the number of shares of the Companys common stock outstanding immediately after giving effect to its conversion. In addition, until such time as the Company has received shareholder approval as required by applicable Nasdaq rules, the Company may not issue, upon conversion of the October Preferred Stock or exercise of the October Investor Warrant, a number of shares of common stock which, when aggregated with the October Registered Stock or the shares previously issued upon conversion, would exceed 19.99% of the total number of shares of common stock outstanding immediately prior to this transaction

Series D-1 Preferred Stock [Member] | October 2014 Financing [Member] | Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Preferred Stock, Par or Stated Value Per Share

$0.00

Share Price

$1,000

Conversion of Stock, Shares Converted

1,060,000

Conversion of Stock, Shares Issued

1,060

Debt Instrument, Convertible, Conversion Price

$1.31

Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value

4,060,000

Series D-2 Preferred Stock [Member] | October 2014 Financing [Member] | Securities Purchase Agreement [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Preferred Stock, Par or Stated Value Per Share

$0.00

Share Price

$1,000

Common Stock Acquired In Joint Venture

5,000,000

Conversion of Stock, Shares Converted

940,000

Conversion of Stock, Shares Issued

940

Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value

940,000

Green Planet [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Stock Issued During Period, Shares, New Issues

93,750

Other Income

43,750

Common Stock [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Common Stock, Par or Stated Value Per Share

$0.00

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

682,035

Stock Issued During Period, Shares, New Issues

2,821,889

2,728,139

Stock Issued During Period, Value, New Issues

2,822

Class of Warrant or Right, Exercise Price of Warrants or Rights

$1.35

Stock Issued During Period, Shares, Issued for Services

394,606

959,499

Common Stock [Member] | Over-Allotment Option [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

88,961

Proceeds from Issuance or Sale of Equity

$2,455,325

Shares Issued, Price Per Share

$0.90

Warrant [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Stock Issued During Period, Shares, New Issues

2,728,139

Warrant [Member] | Over-Allotment Option [Member]

Summary Of Outstanding Options And Warrants [Line Items]

Stock Issued During Period, Shares, New Issues

355,844

Related_Party_Transactions_Det

Related Party Transactions (Details Textual) (USD $)	1 Months Ended			12 Months Ended	1 Months Ended
	Jan. 31, 2011	Jun. 25, 2010	Apr. 30, 2008	Dec. 31, 2014	Feb. 29, 2008	Dec. 31, 2013
	Squarefeets		Squarefeets
Related Party Transaction [Line Items]
Operating Leases, Rent Expense	$4,000
Stock Issued During Period, Value, Acquisitions		23,750
Stock Issued During Period, Shares, Acquisitions		25,000
Business Acquisition, Share Price		$0.95
Common Stock, Shares, Issued				36,691,505		36,691,505
Related Party Transaction Monthly Lease Payments			2,500
Related Party Transaction Occupy Leased Square Feet			3,000
Area Of Building Square Foot			6,000
Related Party Transaction Expended Occupy Leased Square Feet	5,000
Percentage Of Ownership Acquired		20.00%
Directors Compensation Methodology				This compensation was paid in the form of common stock equivalent shares, calculated based on the average common share price during the last 10 business days of each quarter.
Board of Directors Chairman [Member]
Related Party Transaction [Line Items]
Officers' Compensation				20,000
Dr. Ruggero Santilli, Chairman and Chief Scientist [Member]
Related Party Transaction [Line Items]
Common Stock, Shares, Issued					10,000
Related Party Transaction, Amounts of Transaction					5,000
Due to Employees					15,000
Period Of Consulting Agreement					5 years
Ermanno Santilli, Chief Executive Officer, Director [Member]
Related Party Transaction [Line Items]
Annual Salary Payable To Related Parties				130,000
Term Of Related Parties				31-Mar-14
Luisa Ingargiola, Chief Financial Officer, Director [Member]
Related Party Transaction [Line Items]
Annual Salary Payable To Related Parties				120,000
Term Of Related Parties				31-Mar-14

Product_Line_Information_Detai

Product Line Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting [Line Items]
Revenue	$1,023,046	$988,986
Costs	673,867	548,478
Margin	349,179	440,508
Unit Sales [Member]
Segment Reporting [Line Items]
Revenue	54,341	459,659
Costs	64,983	203,551
Margin	-10,642	256,108
License Fees [Member]
Segment Reporting [Line Items]
Revenue	93,332	93,332
Costs	0	0
Margin	93,332	93,332
Metal Cutting [Member]
Segment Reporting [Line Items]
Revenue	875,373	435,995
Costs	608,884	344,927
Margin	$266,489	$91,068

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (Subsequent Event [Member], USD $)	Dec. 31, 2014
Subsequent Event [Line Items]
Property Plant And Equipment Commercial Agreement Amount	$675,000
Commercial Agreement [Member]
Subsequent Event [Line Items]
Property Plant And Equipment Commercial Agreement Amount	$450,000